|
1
|
Ferguson MK, DeMeester TR, DesLauriers J,
et al: Diagnosis and management of synchronous lung cancer. J
Thorac Cardiovasc Surg. 89:378–385. 1985.
|
|
2
|
Martini N and Melamed MR: Multiple primary
lung cancers. J Thorac Cardiovasc Surg. 70:606–612. 1975.
|
|
3
|
Wang X, Christiani DC, Mark EJ, et al:
Carcinogen exposure, p53 alteration, and K-ras mutation in
synchronous multiple primary lung carcinoma. Cancer. 85:1734–1739.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miura H, Nakajima N, Ikeda N, et al:
Therapeutic strategy for secondary lung cancer. Kyobu Geka.
63:956–961. 2010.PubMed/NCBI
|
|
5
|
Van Rens MTM, Zanen P, de la Riviere AB,
et al: Survival in synchronous versus single lung cancer: upstaging
better reflects prognosis. Chest. 118:952–958. 2000.PubMed/NCBI
|
|
6
|
Lam S, MacAulay C and Palcic B: Detection
and localization of early lung cancer by imaging techniques. Chest.
103:S12–S14. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Woolner LB, Fontana RS, Cortese DA, et al:
Roentgenographically occult lung cancer: pathologic findings and
frequency of multicentricity during a 10-year period. Mayo Clin
Proc. 59:453–466. 1984.PubMed/NCBI
|
|
8
|
Morita T: Incidence, contents and change
of autopsied multiple primary cancers of the lung based on the
annual of the autopsy cases in Japan between 1958 and 1992. Haigan.
37:283–294. 1997. View Article : Google Scholar
|
|
9
|
Saito Y, Fujimura S, Sato M, et al: Recent
advances in diagnosis and treatment of multiple primary lung
cancers. Nippon Kyobu Rinsho. 52:95–101. 1993.
|
|
10
|
Matsuge S, Hosokawa Y, Sato K, et al:
Surgical treatment for bilateral multiple lung cancers. Kyobu Geka.
53:89–94. 2000.
|
|
11
|
Niho S, Nishiwaki Y, Goto K, et al:
Significance of serum pro-gastrin-releasing peptide as a predictor
of relapse of small cell lung cancer: comparative evaluation with
neuron-specific enolase and carcinoembryonic antigen. Lung Cancer.
27:159–167. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shibayama T, Ueoka H, Nishii K, et al:
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and
neuron specific enolase (NSE) in diagnosis and prognosis of small
cell lung cancer (SCLC). Lung Cancer. 32:61–69. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jorgensen LGM, Osterlind K, Genolla J, et
al: Serum neuron-specific enolase (S-NSE) and the prognosis in
small-cell lung cancer (SCLC): a combined multivariable analysis on
data from nine centres. Br J Cancer. 74:463–467. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Molina R, Filella X and Auge JM: ProGRP: a
new biomarker for small cell lung cancer. Clin Biochem. 37:505–511.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stieber P, Dienemann H, Schalhorn A, et
al: Pro-gastrin-releasing peptide (ProGRP) - a useful marker in
small cell lung carcinomas. Anticancer Res. 19:2673–2678.
1999.PubMed/NCBI
|
|
16
|
Lamy PJ, Grenier J and Pujol JL:
Pro-gastrin-releasing peptide, neuron specific enolase and
chromogranin A as serum markers of small cell lung cancer. Lung
Cancer. 29:197–203. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goto K, Kodama T, Hojo F, et al:
Clinicopathologic characteristics of patients with nonsmall cell
lung carcinoma with elevated serum progastrin-releasing peptide
levels. Cancer. 82:1056–1061. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Molina R, Auge JM, Bosch X, et al:
Usefulness of serum tumor markers, including progastrin-releasing
peptide, in patients with lung cancer: correlation with histology.
Tumor Biol. 30:121–129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van Rens MTM, de la Riviere AB, Elbers
HRJ, et al: Prognostic assessment of 2,361 patients who underwent
pulmonary resection for non-small cell lung cancer stage I, II and
IIIA. Chest. 117:374–379. 2000.PubMed/NCBI
|
|
20
|
Chang YL, Wu CT and Lee YC: Surgical
treatment of synchronous multiple primary lung cancers: experience
of 92 patients. J Thorac Cardiovasc Surg. 134:630–637. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adebonojo SA, Moritz DM and Danby CA: The
results of modern surgical therapy for multiple primary lung
cancers. Chest. 112:693–701. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsunezuka Y, Matsumoto I, Tamura M, et al:
The results of therapy for bilateral multiple primary lung cancers:
30 years experience in a single centre. Eur J Surg Oncol.
30:781–785. 2004.PubMed/NCBI
|
